It has been reported that SEMA3B-AS1 was deemed as a novel cancer suppressor in gastric cardia adenocarcinoma, esophageal squamous cell carcinoma, and hepatocellular carcinoma (37–39). The gene discussed is SEMA3B; the disease is gastric cardia adenocarcinoma.